OBJECTIVE: The experience accrued at the University of Pittsburgh between March 1982 and December 1992 in the various forms of lung transplantation, including heart-lung, double lung, and single lung, is discussed. SUMMARY BACKGROUND DATA: Heart-lung (n = 97) was the most commonly performed operation followed by double lung (n = 80) and single lung (n = 68). Major indications included primary pulmonary hypertension (n = 76), obstructive lung disease (n = 57), Eisenmenger's syndrome (n = 42), cystic fibrosis (n = 32), and retransplantation (n = 13). Since May 1991, 115 procedures have been performed and heart-lung transplantation has decreased from 61% to 15% of the cases with a corresponding doubling in double lung from 24% to 43% and single lung from 15% to 42%. RESULTS: The 1-, 2-, and 5-year survival rates in all 232 recipients were 61%, 55%, and 44%, respectively. The actuarial survival rate was significantly better for those 107 recent recipients compared to the 125 early recipients (70% vs. 61%). Overall, the 63 single (70%) and 74 double (65%) lung procedures were more successful than heart-lung transplantation (53%). Recently, however, lung transplantation has been associated with an improvement in the survival rate from 48% to 72%. The survival rate has also improved from 53% to 77% for single lung transplant recipients. The causes of death in 106 recipients included infection (n = 40), early allograft dysfunction (n = 23), obliterative bronchiolitis (n = 13), and inoperative bleeding (n = 10). Poor outcomes also included technical problems (n = 6), lymphoma (n = 4), acute rejection (n = 3), diaphragmatic paralysis (n = 2), multisystem organ failure (n = 2), stroke (n = 2), liver failure (n = 1), and airway dehiscence (n = 1). CONCLUSIONS: The long-term outlook for lung transplant recipients has improved. There appears to be significant conservation of organs with single lung and double lung transplantation, finding greater acceptance for diseases once exclusively treated by heart-lung transplantation alone. The improved long-term outlook will be dependent upon better treatment for chronic rejection of the airways that histologically is defined by obliterative bronchiolitis.
OBJECTIVE: The experience accrued at the University of Pittsburgh between March 1982 and December 1992 in the various forms of lung transplantation, including heart-lung, double lung, and single lung, is discussed. SUMMARY BACKGROUND DATA: Heart-lung (n = 97) was the most commonly performed operation followed by double lung (n = 80) and single lung (n = 68). Major indications included primary pulmonary hypertension (n = 76), obstructive lung disease (n = 57), Eisenmenger's syndrome (n = 42), cystic fibrosis (n = 32), and retransplantation (n = 13). Since May 1991, 115 procedures have been performed and heart-lung transplantation has decreased from 61% to 15% of the cases with a corresponding doubling in double lung from 24% to 43% and single lung from 15% to 42%. RESULTS: The 1-, 2-, and 5-year survival rates in all 232 recipients were 61%, 55%, and 44%, respectively. The actuarial survival rate was significantly better for those 107 recent recipients compared to the 125 early recipients (70% vs. 61%). Overall, the 63 single (70%) and 74 double (65%) lung procedures were more successful than heart-lung transplantation (53%). Recently, however, lung transplantation has been associated with an improvement in the survival rate from 48% to 72%. The survival rate has also improved from 53% to 77% for single lung transplant recipients. The causes of death in 106 recipients included infection (n = 40), early allograft dysfunction (n = 23), obliterative bronchiolitis (n = 13), and inoperative bleeding (n = 10). Poor outcomes also included technical problems (n = 6), lymphoma (n = 4), acute rejection (n = 3), diaphragmatic paralysis (n = 2), multisystem organ failure (n = 2), stroke (n = 2), liver failure (n = 1), and airway dehiscence (n = 1). CONCLUSIONS: The long-term outlook for lung transplant recipients has improved. There appears to be significant conservation of organs with single lung and double lung transplantation, finding greater acceptance for diseases once exclusively treated by heart-lung transplantation alone. The improved long-term outlook will be dependent upon better treatment for chronic rejection of the airways that histologically is defined by obliterative bronchiolitis.
Authors: B P Griffith; R L Hardesty; A Trento; I L Paradis; R J Duquesnoy; A Zeevi; J H Dauber; J S Dummer; M E Thompson; S Gryzan Journal: Ann Thorac Surg Date: 1987-01 Impact factor: 4.330
Authors: B A Reitz; J L Wallwork; S A Hunt; J L Pennock; M E Billingham; P E Oyer; E B Stinson; N E Shumway Journal: N Engl J Med Date: 1982-03-11 Impact factor: 91.245
Authors: J H Calhoon; F L Grover; W J Gibbons; C L Bryan; S M Levine; S R Bailey; L Nichols; C Lum; J K Trinkle Journal: J Thorac Cardiovasc Surg Date: 1991-05 Impact factor: 5.209
Authors: R D Dowling; N Baladi; M Zenati; J S Dummer; R L Kormos; J M Armitage; S A Yousem; R L Hardesty; B P Griffith Journal: Ann Thorac Surg Date: 1990-01 Impact factor: 4.330
Authors: G A Patterson; J D Cooper; B Goldman; R D Weisel; F G Pearson; P F Waters; T R Todd; H Scully; M Goldberg; R J Ginsberg Journal: Ann Thorac Surg Date: 1988-06 Impact factor: 4.330
Authors: J M Armitage; F J Fricker; G Kurland; R L Hardesty; M Michaels; S Morita; T E Starzl; S A Yousem; R Jaffe; B P Griffith Journal: J Thorac Cardiovasc Surg Date: 1993-02 Impact factor: 5.209
Authors: B P Griffith; R L Hardesty; J M Armitage; R L Kormos; G C Marrone; S Duncan; I Paradis; J H Dauber; S A Yousem; P Williams Journal: Ann Thorac Surg Date: 1992-11 Impact factor: 4.330
Authors: A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl Journal: Ann Transplant Date: 1997 Impact factor: 1.530
Authors: B P Griffith; K Bando; R L Hardesty; J M Armitage; R J Keenan; S M Pham; I L Paradis; S A Yousem; K Komatsu; H Konishi Journal: Transplantation Date: 1994-03-27 Impact factor: 4.939